92 filings
Page 2 of 5
8-K
bdbk1jp
29 Jun 22
Termination of a Material Definitive Agreement
9:26pm
8-K
2us8iv4tqakp7ku13b6
17 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
xq8 ov0gya0f9gt2wrt
12 May 22
Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate Update
7:16am
8-K
suu865xws
17 Mar 22
Entry into a Material Definitive Agreement
5:29pm
8-K
e3tkr2u3
17 Mar 22
Aadi Reports Fourth Quarter and Full Year 2021 Financial Results
7:10am
8-K
cf64nlr9tetp vtw
19 Jan 22
Entry into a Material Definitive Agreement
9:55pm
8-K
rcqgfxh10so
23 Nov 21
Other Events
6:27am
8-K
1xo5pp
10 Nov 21
Aadi Reports Third Quarter 2021 Financial Results
7:16am
8-K
nprvfv7np3e20f
1 Nov 21
Aadi Bioscience Appoints Scott Giacobello as Chief Financial Officer
4:29pm
8-K/A
bjdez8ee
24 Sep 21
Index to Financial Statements
4:41pm
8-K
lkuv3sth 8c
20 Sep 21
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
9:00am
8-K
4o5w75
13 Sep 21
Aadi Bioscience Appoints Emma Reeve to its Board of Directors
8:27am
8-K
k5md6yuubwyugm
3 Sep 21
Entry into a Material Definitive Agreement
4:58pm
8-K
mln35z3s
26 Aug 21
Entry into a Material Definitive Agreement
9:36pm
8-K
i7bq8qn
23 Aug 21
Entry into a Material Definitive Agreement
5:27pm
8-K
zima8zbbcz201z
18 Aug 21
Submission of Matters to a Vote of Security Holders
12:00am
8-K
auik3v4qui6o5p1xb18c
11 Aug 21
Aerpio Reports Second Quarter 2021 Financial Results
4:20pm
8-K
kvbxcttc22drq lh
26 Jul 21
Aadi Bioscience Announces FDA Acceptance and Priority Review for the New Drug Application of FYARROâ„¢ for the Treatment of Advanced Malignant PEComa
8:01am
8-K
gpb14fttt9cbsd6j
4 Jun 21
Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting
9:35am
8-K
krdamo0ag59gpf
20 May 21
Aerpio Provides Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting
7:00am